Smith & Nephew (SNN) Consolidated Net Income (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Consolidated Net Income of $167.0 million for Q4 2024, down 33.2% year-on-year from $250.0 million in Q1 2024, and down 33.2% on a QoQ basis from $250.0 million in Q4 2023.
Smith & Nephew (SNN) Consolidated Net Income (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Consolidated Net Income for 16 consecutive years, with $167.0 million the latest figure, recorded in Q4 2024.
- Quarterly Consolidated Net Income fell 33.2% year-over-year to $167.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $167.0 million (down 74.23% YoY) and the FY2025 annual result came in at $625.0 million, up 51.7% from the prior year.
- Consolidated Net Income fell to $167.0 million in Q4 2024 per SNN's latest filing, from $250.0 million in the prior quarter.
- Over the last five years, Consolidated Net Income for SNN reached as high as $250.0 million in Q4 2023 and fell as low as -$168.0 million in Q4 2020.
- A 5-year average of $144.2 million and a median of $231.0 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2020 — Consolidated Net Income sank 131.94% — and 2021, when it jumped 243.45%.
- Year by year, Consolidated Net Income stood at -$168.0 million in 2020, then soared by 243.45% to $241.0 million in 2021, then declined by 4.15% to $231.0 million in 2022, then grew by 8.23% to $250.0 million in 2023, then sank by 33.2% to $167.0 million in 2024.
- According to Business Quant data, Consolidated Net Income over the past three periods registered $167.0 million, $250.0 million, and $231.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Steris | 21.41 Bn | 20.97 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 167.00 Mn |
| Dec 31, 2023 | 250.00 Mn |
| Dec 31, 2022 | 231.00 Mn |
| Dec 31, 2021 | 241.00 Mn |
| Dec 31, 2020 | -168.00 Mn |
| Dec 31, 2019 | 526.00 Mn |
| Dec 31, 2018 | 459.00 Mn |
| Dec 31, 2017 | 495.00 Mn |
| Dec 31, 2016 | 605.00 Mn |
| Dec 31, 2015 | 560.00 Mn |
| Dec 31, 2014 | 562.00 Mn |
| Sep 30, 2014 | 204.00 Mn |
| Mar 31, 2014 | 264.00 Mn |
| Dec 31, 2013 | 450.00 Mn |
| Mar 31, 2013 | 302.00 Mn |
| Dec 31, 2012 | 584.00 Mn |
| Jun 30, 2012 | 641.00 Mn |
| Mar 31, 2012 | 286.00 Mn |
| Dec 31, 2011 | 469.00 Mn |
| Sep 30, 2011 | 834.00 Mn |